NSE › Healthcare

Marksans Pharma Limited (MARKSANS)

NSE · Healthcare · Drug Manufacturers - General

₹262.25+6.48%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
₹856 cr
Revenue YoY
+20.8%
Net profit
₹148 cr
Profit YoY
+63.6%
EPS
₹3.27
EPS estimate
₹3.30
Net margin
17.3%

EPS came in at 3.27 against a street estimate of 3.30 — a miss of 0.9%.

Key statistics

Market cap
₹11,692 cr
P/E
28.0
Forward P/E
13.9
P/B
3.87
Book value
₹66.74
EPS (TTM)
₹9.22
52-week high
₹281.60
52-week low
₹155.00
50-day MA
₹256.17
200-day MA
₹199.97
Beta
1.09

Analyst view

with an average price target of ₹266.00.

Shareholding

Promoters
43.87%
Institutions
18.60%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Marksans Pharma Limited — free to start.

Google PlayApp Store

Other Healthcare companies

Sun Pharmaceutical Industries LimitedDivi's Laboratories LimitedTorrent Pharmaceuticals LimitedApollo Hospitals Enterprise LimitedCipla LimitedZydus Lifesciences LimitedLupin LimitedMax Healthcare Institute LimitedMankind Pharma LtdLaurus Labs LimitedLenskart Solutions LtdDr. Reddy's Laboratories Limited

Data updated 2026-08-05.